Covid 19 And The Dermatologist An Issue Of Dermatologic Clinics E Book

This issue of Dermatologic Clinics, guest edited by Dr. Esther Freeman and Devon McMahon, will focus on COVID-19 and the Dermatologist. This issue is one of four selected each year by our series Consulting Editor, Dr. Bruce Thiers. Topics discussed in this issue include but are not limited to Covid-19 as it pertains to Dermatology Residency, Race in Dermatology, Dermatology Practice changes, Global Health Dermatology, Dermatologic Morphologies, Teledermatology, Dermatology Immunology, Occupational dermatology, Biologics, In-Patient Dermatology, Pediatric Dermatology, Registry Update, Dermatopathology, and Effect of COVID-19 on Delayed Skin Cancer Services. Provides in-depth, clinical reviews on COVID-19 and the Dermatologist, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.

Since the first cases of an acute respiratory illness were reported, the pathogen SARS-coV-2 (severe acute respiratory syndrome coronavirus 2) and its disease, COVID-19 have disrupted the world and changed the course of medical history. Clinics were under lockdown and supplies of critical drugs such as biologics and meladinine were delayed. The prolonged impact of disease has taken its toll on patients, their careers, medical staff, research and medical education. Shortly after the first landmark studies of COVID-19 vaccine trial data were made known, global mass vaccination programs were underway. Vaccine technology has expanded beyond messenger RNA (mRNA) to include non-replicating viral vectors, inactivated virus, and protein subunits. Cutaneous manifestations of vaccine reactions, including non-mRNA and their morphological patterns, indications and contraindications, vaccine global access, equity, allocation of booster doses, emerging COVID variants and subvariants, waning vaccine and treatment efficacy are the issues that begged to be explored. New oral therapies are available for treatment of COVID-19 but they bring with them drug-drug interactions and potential side effects. This book is a compilation of a concerted effort by dermatologists across the globe to join hands against COVID-19. Each chapter has been written by experts in the field, with first-hand experience and synthesized literature to offer the most up-to-date coverage in the fast-paced, changing landscape of COVID-19 in dermatology. COVID-19 in Dermatology is a valuable resource for dermatologists, dermatology residents and medical students, and general practitioners.

In this issue of Dermatologic Clinics, Guest Editor Kelly M. Cordoro brings considerable expertise to the topic of Pediatric Dermatology. Top experts in the field cover key topics such as Epidermal Nevi in Children, Pigmented Lesions in Children, Normal Skin Findings in Pediatric Patients with Skin of Color, and more. Provides in-depth, clinical reviews on pediatric dermatology, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews. Contains 11 relevant, practice-oriented topics including Presentation of common skin disorders in pediatric patients with skin of color; Tips, Tricks and Pearls to Expertly Treating Common Skin Conditions in Pediatric Patients; Climate and Environmental Health as it Relates to Pediatric Dermatology; and more.

Since the first cases of an acute respiratory illness were reported, the pathogen SARS-coV-2 (severe acute respiratory syndrome coronavirus 2) and its disease, COVID-19 have disrupted the world and changed the course of medical history. Clinics were under lockdown and supplies of critical drugs such as biologics and meladinine were delayed. The prolonged impact of disease has taken its toll on patients, their careers, medical staff, research and medical education. Shortly after the first landmark studies of COVID-19 vaccine trial data were made known, global mass vaccination programs were underway. Vaccine technology has expanded beyond messenger RNA (mRNA) to include non-replicating viral vectors, inactivated virus, and protein subunits. Cutaneous manifestations of vaccine reactions, including non-mRNA and their morphological patterns, indications and contraindications, vaccine global access, equity, allocation of booster doses, emerging COVID variants and subvariants, waning vaccine and treatment efficacy are the issues that begged to be explored. New oral therapies are available for treatment of COVID-19 but they bring with them drug-drug interactions and potential side effects. This book is a compilation of a concerted effort by dermatologists across the globe to join hands against COVID-19. Each chapter has been written by experts in the field, with first-hand experience and synthesized literature to offer the most up-to-date coverage in the fast-paced, changing landscape of COVID-19 in dermatology. COVID-19 in Dermatology is a valuable resource for dermatologists, dermatology residents and medical students, and general practitioners.

In this issue of Dermatologic Clinics, guest editor Dr. Kelly M. Cordoro brings her considerable expertise to the topic of Pediatric Dermatology. Top experts in the field cover key topics such as neutrophilic dermatoses in children; laser surgery for dermatologic conditions in pediatric patients; managing children/families with delusions of infestation/parasitosis; counterfeit medications; and more. Contains 11 relevant, practice-oriented topics including clinical relevance of the cutaneous microbiome in pediatric skin disease; systemic therapy for vascular malformations and the status of genotype-guided management; systemic therapy for pediatric atopic dermatitis; update on biologic therapy for pediatric psoriasis; hormonal treatment of acne in adolescent patients; and more. Provides in-depth clinical reviews on pediatric dermatology, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

This issue of Dermatologic Clinics, guest edited by Drs. Victoria Williams and Carrie Kovarik, will cover a number of important topics in Global Dermatology and Telemedicine. This issue is one of four each year selected by long-time series Consulting Editor, Dr. Bruce Thiers. Topics discussion include, but are not limited to: Patterns of Skin Disease in the Context of a High Prevalence HIV Population in Botswana; Telemedicine and Community Health Projects in Asia; Utilizing Technology for Dermatology Care in Tajikistan: A Health Systems Perspective; Community Outreach Projects to Increase Dermatology Education and Access to Care in Argentina; Challenges and Successes of Dermatology Training Programs in Africa; Developing an Electronic Platform for Global Dermatology Mentorship and Collaboration; Novel Diagnostics for Kaposi Sarcoma and Other Skin Diseases in Resource Poor Settings; Implementing a Locally Made Low-Cost Intervention for Wound and Lymphedema Care in Western Kenya; Challenges of Managing Skin Disease in Migrants and Refugees; Factors Affecting Quality of Life for People Living with Albinism in Botswana; and Integration of Management Strategies for Neglected Tropical Diseases Affecting the Skin

This issue of Dermatologic Clinics, guest edited by Dr. Neil S. Sadick, will cover a number of key topics related to Hair. This issue is one of four each year selected by longtime series Consulting Editor, Dr. Bruce Thiers. Articles in this issue include: Clinical patterns of hair loss in men: Is DHT the only culprit?; Understanding causes of hair loss in women; New diagnostic tools to evaluate hair loss; FDA approved treatments for hair loss; Frontal fibrosing alopecia: is it the new epidemic?; Scarring alopecia: diagnosis and new treatment options; Central centrifugal alopecia: challenges and treatments;Alopecia areata: new treatment options including JAK inhibitors; Trichoceuticals; Platelet-rich plasma and cell therapy: the new horizon in hair loss treatment; Energy-based devices for hair loss; Follicular unit extraction for hair transplantation: an update; Automated devices for hair transplantation; and Combination approaches for combatting hair loss.

In this issue, guest editors bring their considerable expertise to this important topic. Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.